US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug - Reuters
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNV2FXR19tUWxiQ2RMdWp5SHJZUFlpSEUtamdIMXdReTd4UzV0Zm0xODZCeGE0bEt4Nmd2MVV6akl6OGtQdVVwNTlEczIwcHVhVGNHVVplMUROQUZoUTFKcHI1ajY1Y3UydGZsZGtsM3duc3BDeDlWQl9LaGtaNFgtMk1LbWcwTXlkVEpIOEMtTGppOTFJMVBPX3RnS0xOaFR1ekhyWlhHMTlLYWplclF4LTFvd3NFWC02V2NrOE9VQzNtX0R0RmJz?oc=5" target="_blank">US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug</a> <font color="#6f6f6f">Reuters</font>
U.S. cancer centers are urgently enrolling patients in an early access program for Revolution Medicines' experimental drug daraxonrasib, following its FDA-approved expanded access program on May 1, 2026.
Medscape reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, highlighting the FDA's recent approval for expanded access.
Medscape discusses the urgency among U.S. cancer clinics to provide patients with access to Revolution Medicines' experimental drug daraxonrasib, following the FDA's approval for expanded access.
Medscape reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, following the FDA's recent approval for expanded access.
Medscape discusses the urgency among U.S. cancer clinics to provide patients with access to Revolution Medicines' experimental drug daraxonrasib, following the FDA's approval for expanded access.
Yahoo News Malaysia reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, following the FDA's recent approval for expanded access.
Similar Stories
Related coverage based on topic and tags
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMUS drug agency approves breakthrough treatment for pancreatic cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.
August 26, 2026 at 10:02 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMThe Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? - Reuters
The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? Reuters
August 25, 2026 at 04:32 PM